Inhibition of microRNA-660-5p Decreases Breast Cancer Progression
Author Information
Author(s): Villarreal-García Valeria, Estupiñan-Jiménez José Roberto, Gonzalez-Villasana Vianey, Vivas-Mejía Pablo E., Flores-Colón Marienid, Ancira-Moreno Irma Estefanía, Zapata-Morín Patricio Adrián, Altamirano-Torres Claudia, Vázquez-Guillen José Manuel, Rodríguez-Padilla Cristina, Bayraktar Recep, Rashed Mohamed H., Ivan Cristina, Lopez-Berestein Gabriel, Reséndez-Pérez Diana
Primary Institution: Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, México
Hypothesis
The study aims to investigate the role of miR-660-5p in breast cancer cell proliferation, migration, invasion, and angiogenesis and to identify its potential targets.
Conclusion
Inhibiting miR-660-5p reduces breast cancer cell proliferation, migration, invasion, and angiogenesis.
Supporting Evidence
- MiR-660-5p is significantly overexpressed in breast cancer cells compared to healthy cells.
- Inhibiting miR-660-5p led to a 90% reduction in its expression in breast cancer cells.
- Knockdown of miR-660-5p resulted in a significant decrease in cell proliferation, migration, invasion, and angiogenesis.
Takeaway
This study found that a tiny molecule called miR-660-5p helps breast cancer cells grow and spread, and stopping it can slow down the cancer.
Methodology
The study used cell lines and various assays including RT-qPCR, Western blot, and dual-luciferase reporter assays to analyze the effects of miR-660-5p inhibition.
Statistical Information
P-Value
p=0.0004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website